Analyst Research: Momenta Pharmaceuticals Inc (MNTA.OQ)

MNTA.OQ on NASDAQ Stock Exchange Global Select Market

16.53USD
1 Aug 2013
Price Change (% chg)

$-0.73 (-4.23%)
Prev Close
$17.26
Open
$16.78
Day's High
$16.95
Day's Low
$16.48
Volume
233,326
Avg. Vol
137,075
52-wk High
$18.02
52-wk Low
$10.05

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - MOMENTA PHARMACEUTICALS, INC. (MNTA-O) 6:13am EDT Thomson Reuters Stock Report 11 25.00
ValuEngine Detailed Valuation Report for MNTA 31 Jul 2013 ValuEngine, Inc. 11 25.00
Wright Investors Service Comprehensive Report for Momenta Pharmaceuticals, Inc. 30 Jul 2013 Wright Reports 41 472.00
Momenta Pharmaceuticals 27 Jul 2013 S&P Capital IQ Quantitative Report 6 69.00
MOMENTA PHARMACEUTICALS INC (MNTA) 12-months forecast 26 Jul 2013 Pechala's Reports 1 15.00
Momenta Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 26 Jul 2013 Reuters Investment Profile 12 20.00
MOMENTA PHARMA (MNTA) Zacks Company Snapshot 22 Jul 2013 Zacks Investment Research Inc. 1 12.00
TheStreet.com Ratings Stock Report For: MOMENTA PHARMACEUTICALS INC (MNTA) 20 Jul 2013 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

James Sulat

63 2008 Independent Chairman of the Board

Craig Wheeler

52 2006 President, Chief Executive Officer, Director

Richard Shea

60 2007 Chief Financial Officer, Senior Vice President

Ganesh Kaundinya

45 2007 Senior Vice President - Research, Chief Scientific Officer

Bruce Leicher

56 2008 Senior Vice President, General Counsel, Secretary
Search Stocks